跳至主要内容
临床试验/NCT01212159
NCT01212159已完成4 期

Telephone Based Management of Hyperlipidemia Utilizing a Self Monitoring Testing Device

Temple University1 个研究点 分布在 1 个国家目标入组 70 人开始时间: 2010年11月1日最近更新:
适应症
干预措施

试验速览

阶段
4 期
状态
已完成
入组人数
70
试验地点
1
主要终点
LDL Level Change From Baseline

研究概览

简要总结

The purpose of the study is to demonstrate that systematic self measurement of blood lipids reduces LDL cholesterol more effectively than standard care. The hypothesis is that cholesterol lowering medication adherence will be improved with self monitoring and reporting of frequent blood lipids and the percentage of patients achieving LDL goal will be greater than without home monitoring.

详细描述

The study utilizes a telephone reporting system to self report lipid values and provide educational counseling regarding lifestyle modification methods to reduce cardiovascular risk. Study patients will be randomized to receive a home monitoring device and will be instructed on its use. Generic simvastatin will be given to reduce LDL levels in all groups. It is the hypothesis that those study patients receiving a home device will reach target LDL (goal LDL) more frequently than those randomized to usual care( no device).

研究设计

研究类型
Interventional
分配方式
Randomized
干预模型
Parallel
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 80 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •LDL > 130mg/dl

排除标准

  • •Pregnant patients
  • •liver disease
  • •allergic reaction to statins

研究组 & 干预措施

No self monitoring device

No Intervention

Standard or usual care of high LDL including lab lipid profiles after treatment with statin therapy. No device or telemedicine education will be provided

Self Monitoring Lipid Analyzer

Experimental

Self measured blood lipids using a home lipidometer, and telephone reporting of data to the clinical center.

干预措施: Self Monitoring Lipid Analyzer (Device)

结局指标

主要结局

LDL Level Change From Baseline

时间窗: baseline to 6 months

Comparison of serum LDL level between control and intervention subjects

次要结局

  • Medication Compliance(6 months)
  • LDL Values at Two Week Interval(6 weeks)

研究者

申办方类型
Other
责任方
Principal Investigator
主要研究者

Alfred A Bove, MD, PhD

Emeritus Professor of Medicine

Temple University

研究点 (1)

Loading locations...

相似试验